Načítá se...
Efficacy and safety of Samtropin™ recombinant human growth hormone; a double-blind randomized clinical trial
BACKGROUND: Recombinant human growth hormone (rhGH) can increase the growth rate in growth hormone deficient children (GHD). In this randomized clinical trial, we compared the efficacy and side effects of an Iranian brand; Samtropin with Norditropin. METHODS: The GHD children were randomly treated e...
Uloženo v:
| Vydáno v: | J Diabetes Metab Disord |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4304100/ https://ncbi.nlm.nih.gov/pubmed/25648850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40200-014-0115-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|